Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
25.36
+0.42 (1.70%)
Jun 26, 2026, 4:00 PM EDT - Market closed
THNR Holdings List
As of Jun 23, 2026
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 9.95% |
| 2 | LLY | Eli Lilly and Company | 8.90% |
| 3 | SRRK | Scholar Rock Holding Corporation | 5.61% |
| 4 | VKTX | Viking Therapeutics, Inc. | 5.50% |
| 5 | HIMS | Hims & Hers Health, Inc. | 5.42% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.14% |
| 7 | HKG: 1801 | Innovent Biologics, Inc. | 5.05% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 5.03% |
| 9 | ABBV | AbbVie Inc. | 5.00% |
| 10 | SWX: ROP | Roche Holding AG | 4.95% |
| 11 | LON: AZN | AstraZeneca PLC | 4.95% |
| 12 | AMGN | Amgen Inc. | 4.89% |
| 13 | MRK | Merck & Co., Inc. | 4.78% |
| 14 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 4.71% |
| 15 | PFE | Pfizer Inc. | 4.52% |
| 16 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.50% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 3.48% |
| 18 | KLRA | Kailera Therapeutics, Inc. | 2.46% |
| 19 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.29% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 2.11% |
| 21 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class | 0.50% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.21% |
| 23 | n/a | JAPANESE YEN | 0.04% |
As of Jun 23, 2026